CVC Investments and New Business Creation by C&Rインキュベーション・ラボ
First written in FY2023-Q3. 4 of 7 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-10-08.
15 other companies' latest entry also says "Advanced".
- FY2026-H1ReframedAnnual report
「In addition, C&R EVERLASTING STORY, whose corporate name was changed from C&R Incubation Lab on 1 June 2025, is accelerating its business with the aim of viewing business managers as professionals, providing opportunities for talented management personnel to thrive, and resolving the challenges surrounding the succession of sound companies, which have become a social issue.」
The corporate name changed from C&R Incubation Lab to C&R EVERLASTING STORY, and its business positioning changed from an emphasis on acquiring seeds through CVC activities to providing opportunities for management personnel to thrive and resolving business succession challenges at sound companies. - FY2025-H1AdvancedAnnual report
「Consolidated subsidiary C&R Incubation Lab operates as a corporate venture capital firm that actively invests in companies expected to generate business synergies with the Group. It creates synergies with existing businesses and acquires seeds related to new businesses. Through business succession and corporate revitalization, it contributes to expanding the Group and creating new services by combining professional expertise.」
The role of C&R Incubation Lab’s CVC function in expanding the Group through business succession and corporate revitalization and creating new services has been defined more specifically. - FY2024-Q3RestatedAnnual report
「Consolidated subsidiary C&R Incubation Lab operates as a CVC (corporate venture capital) that actively invests in companies expected to generate business synergies with the C&R Group. It creates synergies with existing businesses and acquires seeds related to launching new businesses, while accelerating operations leading to the creation of new services by combining professional expertise.」
C&R Incubation Lab continues to make investments, create business synergies, and acquire seeds for new businesses. - FY2023-Q3First statedAnnual report
「Established in October 2022, consolidated subsidiary C&R Incubation Lab operates as a CVC (corporate venture capital) that actively invests in companies expected to generate business synergies with the C&R Group. It creates synergies with existing businesses and acquires seeds for launching new businesses, while accelerating operations aimed at creating new services by combining professional expertise.」
C&R Incubation Lab, established in October 2022, became a consolidated subsidiary, and a new CVC function was established to invest in companies expected to generate synergies, acquire seeds for new businesses, and create new services.